Clinical trial

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma

NCT02229981

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2014-07-01Date precision: month

Registry last updated2017-12-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diffuse Large B Cell Lymphomaunresolved

Kaposi Sarcomaunresolved

Interventions

ABC294640DRUG

Sponsors & collaborators

RedHill Biopharma Limitedlead sponsor

Louisiana State University Health Sciences Center in New Orleanscollaborator

Apogee Biotechnology Corporationcollaborator

Mapped research locations

New OrleansLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02229981 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.